The third quarter of 2025 closed amid growing macroeconomic strain, policy unpredictability and renewed investor focus on execution risk. While ...
FDA Fast Track designation -- The BRTX-100 program was granted Fast Track status by the FDA for chronic lumbar disc disease ...
PyroGenesis Inc. (“PyroGenesis”) (TSX:PYR) (OTCQX:PYRGF) (FRA:8PY1), the leader in ultra-high temperature processes & engineering innovation, and a plasma-based technology provider to heavy industry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback